Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer
Clinical trial NCT00988208 · COMPLETED
Trial details
- NCT number
- NCT00988208
- Sponsor
- Celgene
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-11
- Primary completion
- 2012-01-13
- Enrollment
- 1059
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.